Certified by Founder Lodge
Ampersand Capital Partners
United States - Wellesley, MA
INVESTOR
1 Disclosed Funding Rounds $21,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 1988, Ampersand is a middle-market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector. With
| Company | Date | Round | Raised |
|---|---|---|---|
 Vernal Biosciences |
June, 02 ,2022 | Seed | $21,000,000 |
 NanoImaging Services |
June, 12 ,2023 | Unknown | |
 Genezen |
November, 03 ,2023 | Unknown | $18,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
DexMat | $5,000,000 | (Feb 3, 2026)
